JP2002541067A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002541067A5 JP2002541067A5 JP2000599782A JP2000599782A JP2002541067A5 JP 2002541067 A5 JP2002541067 A5 JP 2002541067A5 JP 2000599782 A JP2000599782 A JP 2000599782A JP 2000599782 A JP2000599782 A JP 2000599782A JP 2002541067 A5 JP2002541067 A5 JP 2002541067A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- pap20
- peptide
- peptide variant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 101100084013 Arabidopsis thaliana PAP20 gene Proteins 0.000 description 1
- 230000009946 DNA mutation Effects 0.000 description 1
- 101001133056 Homo sapiens Mucin-1 Proteins 0.000 description 1
- 102100034256 Mucin-1 Human genes 0.000 description 1
- 101100098812 Mus musculus Tasor2 gene Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19906615A DE19906615A1 (de) | 1999-02-17 | 1999-02-17 | Peptid-Varianten des Tumormarkers MUC1 und ihre Verwendung |
| DE19906615.9 | 1999-02-17 | ||
| PCT/DE2000/000440 WO2000049045A1 (de) | 1999-02-17 | 2000-02-17 | Peptid-varianten des tumormarkers muc1 und ihre verwendung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002541067A JP2002541067A (ja) | 2002-12-03 |
| JP2002541067A5 true JP2002541067A5 (enExample) | 2007-03-15 |
Family
ID=7897778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000599782A Pending JP2002541067A (ja) | 1999-02-17 | 2000-02-17 | 腫瘍マーカーｍｕｃ１のペプチド変異体及びその利用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20090054622A1 (enExample) |
| EP (1) | EP1151005B1 (enExample) |
| JP (1) | JP2002541067A (enExample) |
| AT (1) | ATE243222T1 (enExample) |
| AU (1) | AU772709B2 (enExample) |
| CA (1) | CA2368309A1 (enExample) |
| DE (2) | DE19906615A1 (enExample) |
| DK (1) | DK1151005T3 (enExample) |
| ES (1) | ES2200851T3 (enExample) |
| WO (1) | WO2000049045A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004009632A2 (de) * | 2002-07-22 | 2004-01-29 | Nemod Immuntherapie Ag | Verfahren zur herstellung eines immunstimulatorischen muzins (muc1) |
| WO2011133429A1 (en) | 2010-04-19 | 2011-10-27 | Ezose Sciences, Inc | Cancer-related glycopeptide epitopes, antibodies and methods of use |
| RU2017143985A (ru) | 2011-08-17 | 2019-02-14 | Глоубиммьюн, Инк. | Иммунотерапевтические композиции на основе дрожжей-muc1 и способы их применения |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3023469B2 (ja) * | 1992-02-21 | 2000-03-21 | 株式会社日本抗体研究所 | 糖タンパク質３９遺伝子 |
| US6120765A (en) * | 1993-04-02 | 2000-09-19 | Shiseido Co. Ltd. | Urokinase plasminogen activator fragments |
| US5744144A (en) * | 1993-07-30 | 1998-04-28 | University Of Pittsburgh University Patent Committee Policy And Procedures | Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof |
| AU727308B2 (en) * | 1997-02-24 | 2000-12-07 | Dana-Farber Cancer Institute | Recombinant pox virus for immunization against muc1 tumor-associated antigen |
-
1999
- 1999-02-17 DE DE19906615A patent/DE19906615A1/de not_active Withdrawn
-
2000
- 2000-02-17 AT AT00916753T patent/ATE243222T1/de not_active IP Right Cessation
- 2000-02-17 ES ES00916753T patent/ES2200851T3/es not_active Expired - Lifetime
- 2000-02-17 CA CA002368309A patent/CA2368309A1/en not_active Abandoned
- 2000-02-17 DE DE50002584T patent/DE50002584D1/de not_active Expired - Fee Related
- 2000-02-17 EP EP00916753A patent/EP1151005B1/de not_active Expired - Lifetime
- 2000-02-17 DK DK00916753T patent/DK1151005T3/da active
- 2000-02-17 AU AU38013/00A patent/AU772709B2/en not_active Ceased
- 2000-02-17 WO PCT/DE2000/000440 patent/WO2000049045A1/de not_active Ceased
- 2000-02-17 JP JP2000599782A patent/JP2002541067A/ja active Pending
-
2001
- 2001-08-16 US US09/931,638 patent/US20090054622A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1118443T1 (el) | Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
| NZ503763A (en) | Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use | |
| JP2006512300A5 (enExample) | ||
| EP1847549A3 (en) | Papillomavirus polyprotein constructs | |
| CY1118037T1 (el) | Αντισωματα εναντι του αβητα και h χρηση τους | |
| JP2005504513A5 (enExample) | ||
| JP2003522514A5 (enExample) | ||
| WO2001031019A3 (en) | Neisserial antigenic peptides | |
| HK1053985A1 (zh) | 人類多肽引起或導致殺死細胞，包括淋巴腫瘤細胞 | |
| WO2002080851A3 (en) | Chimeric vaccines | |
| WO2003049762A3 (en) | Immunisation against chlamydia trachomatis | |
| WO2000073430A3 (de) | Vakzine gegen konformationsabhängige antigene sowie gegen antigene, die keine oder nicht ausschliesslich proteine oder peptide sind | |
| JP2002535956A5 (enExample) | ||
| JP2003504062A5 (enExample) | ||
| EP1586646A3 (en) | Lawsonia intracellularis vaccine | |
| JP2007526318A5 (enExample) | ||
| WO2000012535A3 (en) | Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof | |
| JP2002541067A5 (enExample) | ||
| CA2361987A1 (en) | Goodpasture antigen binding protein | |
| WO1994026903A3 (en) | Human influenza virus peptides binding hla-i molecule | |
| CA2327353A1 (en) | Structural proteins of fish pancreatic disease virus and uses thereof | |
| WO1997004099A3 (de) | Papillomviren, mittel zu deren nachweis sowie zur therapie von durch sie verursachten erkrankungen | |
| WO1998042847A3 (de) | Papillomvirus-hauptcapsid-proteins und deren verwendung in diagnose, therapie und vakzinierung | |
| WO1998023752A3 (de) | Papillomviren, mittel zu deren nachweis sowie zur therapie von durch sie verursachten erkrankungen | |
| WO1999009177A3 (de) | Papillomviren, mittel zu deren nachweis sowie zur therapie von durch sie verursachten erkrankungen |